Table 1 Baseline characteristics of the study population
From: Arterial access-site complications after use of a vascular closure device related to puncture height
All patients (n = 95) | Common femoral artery (n = 39) | Femoral bifurcation (n = 37) | Low puncture (n = 19) | p value | |
|---|---|---|---|---|---|
Age, mean ± SD | 69.3 ± 10.5 | 67 ± 10.6 | 70.7 ± 9.7 | 71.4 ± 11.4 | 0.142 |
BMI, mean ± SD | 28.3 ± 5.6 | 26.4 ± 3.7 | 29.5 ± 7.2 | 29.6 ± 4.9 | 0.038 |
Male, n (%) | 61 (64) | 31 (80) | 23 (64) | 7 (37) | 0.006 |
Cardiovascular risk factors, n (%) | |||||
Arterial hypertension | 71 (75) | 26 (67) | 31 (86) | 14 (74) | 0.228 |
Diabetes | 34 (35) | 9 (23) | 16 (44) | 9 (47) | 0.089 |
Smoking | 16 (17) | 10 (26) | 3 (8) | 3 (16) | 0.118 |
Cardiac family history | 12 (13) | 3 (8) | 6 (16) | 3 (16) | 0.484 |
Prior medical history, n (%) | |||||
Congestive heart failure | 12 (13) | 5 (13) | 5 (14) | 2 (11) | 0.922 |
Coronary artery disease | 46 (48) | 16 (41) | 20 (54) | 10 (53) | 0.482 |
Peripheral artery disease | 6 (6) | 3 (8) | 2 (5) | 1 (5) | 1.000 |
Chronic kidney disease | 21 (22) | 5 (13) | 10 (27) | 6 (32) | 0.159 |
Indication for PCI, n (%) | |||||
STEMI | 6 (6) | 2 (5) | 2 (5) | 2 (11) | 0.741 |
NSTEMI | 27 (28) | 12 (31) | 11 (30) | 4 (21) | 0.726 |
Unstable AP | 19 (20) | 9 (24) | 6 (16) | 4 (21) | 0.748 |
Stable AP | 19 (20) | 6 (15) | 8 (21) | 5 (26) | 0.592 |
Other | 24 (25) | 10 (26) | 10 (27) | 4 (21) | 0.887 |
Procedural data | |||||
Average Time | 47 | 52 | 51 | 50 | |
Drug eluting stents, n (%) | 85 (90) | 35 (90) | 33 (89) | 17 (90) | 1.000 |
Bare metal stents, n (%) | 4 (4) | 1 (3) | 2 (5) | 1 (5) | 0.836 |
Total stent length, mean ± SD | 42.4 ± 29.7 | 39.5 ± 24.8 | 42.3 ± 31.7 | 48.3 ± 30.6 | 0.561 |